Gapping up

In reaction to strong earnings/guidance: FSLR +21.3%, CPSS +13.3%, XNN +13.2%, BWLD +12.2%, ATAR +11.9%, XPRT +11.0%, VOLC +8.9%, WSPI +8.8%, RICK +5.6%, OCNF +4.7%, CEPH +4.3% (upgraded to Strong Buy at Broadpoint), PFCB +3.7%, BOBE +3.6%, JNY +3.6%, GXDX +1.6%, ABD +1.5%, NTWK +1.3%, KO +1.1%, VG +1.0%... Other news: BRKS +4.6% (Rio Tinto posts solid results, says BHP must boost offer 'considerably' - WSJ), TASR +2.8% (announces 3 more product liability lawsuit dismissals), DNA +2.2% (announces Avado study of Avastin Plus docetaxel chemotherapy showed improved progression-free survival in patients with advanced breast cancer), CECO +1.7% (announces co-wide restructuring as part of long term growth strategy), PNCL +1.5% (releases January performance data for Colgan Air and Pinnacle Airlines), INTV +1.3% (secures multi-million dollar expansion contract with major U.S. telecommunications company)... Analyst upgrades: DYN +3.3% (upgraded to Buy at Citigroup), BCSI +2.5% (initiated with a Buy at Brean Murray), SGP +1.9% (upgraded to Buy at BofA), VRX +1.7% (upgraded to Peer Perform at Bear Sterns), HL +1.3% (upgraded to Outperform from Market Perform at BMO Capital).